Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Current achievements in the production of complex biopharmaceuticals with moss bioreactors.

Decker EL, Reski R.

Bioprocess Biosyst Eng. 2008 Jan;31(1):3-9. Epub 2007 Aug 14. Review.

PMID:
17701058
2.

The moss bioreactor.

Decker EL, Reski R.

Curr Opin Plant Biol. 2004 Apr;7(2):166-70. Review.

PMID:
15003217
3.

Moss bioreactors producing improved biopharmaceuticals.

Decker EL, Reski R.

Curr Opin Biotechnol. 2007 Oct;18(5):393-8. Epub 2007 Sep 14. Review.

PMID:
17869503
4.

Glycoprotein production in moss bioreactors.

Decker EL, Reski R.

Plant Cell Rep. 2012 Mar;31(3):453-60. doi: 10.1007/s00299-011-1152-5. Epub 2011 Sep 29. Review.

PMID:
21960098
5.

Gene Targeting for Precision Glyco-Engineering: Production of Biopharmaceuticals Devoid of Plant-Typical Glycosylation in Moss Bioreactors.

Decker EL, Wiedemann G, Reski R.

Methods Mol Biol. 2015;1321:213-24. doi: 10.1007/978-1-4939-2760-9_15.

PMID:
26082225
6.

Glyco-engineering of moss lacking plant-specific sugar residues.

Huether CM, Lienhart O, Baur A, Stemmer C, Gorr G, Reski R, Decker EL.

Plant Biol (Stuttg). 2005 May;7(3):292-9.

PMID:
15912449
7.

Use of endogenous signal sequences for transient production and efficient secretion by moss (Physcomitrella patens) cells.

Schaaf A, Tintelnot S, Baur A, Reski R, Gorr G, Decker EL.

BMC Biotechnol. 2005 Nov 7;5:30.

8.

Glyco-engineering for biopharmaceutical production in moss bioreactors.

Decker EL, Parsons J, Reski R.

Front Plant Sci. 2014 Jul 9;5:346. doi: 10.3389/fpls.2014.00346. eCollection 2014. Review.

9.

Physcomitrella patens: a non-vascular plant for recombinant protein production.

Liénard D, Nogué F.

Methods Mol Biol. 2009;483:135-44. doi: 10.1007/978-1-59745-407-0_8.

PMID:
19183897
10.

Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures.

Xu J, Ge X, Dolan MC.

Biotechnol Adv. 2011 May-Jun;29(3):278-99. doi: 10.1016/j.biotechadv.2011.01.002. Epub 2011 Jan 12.

PMID:
21236330
11.

Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern.

Schähs M, Strasser R, Stadlmann J, Kunert R, Rademacher T, Steinkellner H.

Plant Biotechnol J. 2007 Sep;5(5):657-63.

12.

Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans.

Koprivova A, Stemmer C, Altmann F, Hoffmann A, Kopriva S, Gorr G, Reski R, Decker EL.

Plant Biotechnol J. 2004 Nov;2(6):517-23.

13.

Moss-made pharmaceuticals: from bench to bedside.

Reski R, Parsons J, Decker EL.

Plant Biotechnol J. 2015 Oct;13(8):1191-8. doi: 10.1111/pbi.12401. Epub 2015 May 25. Review.

14.

High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-t Delta-xyl-t mutant.

Weise A, Altmann F, Rodriguez-Franco M, Sjoberg ER, Bäumer W, Launhardt H, Kietzmann M, Gorr G.

Plant Biotechnol J. 2007 May;5(3):389-401. Epub 2007 Mar 15.

15.

Post-translational modifications of recombinant proteins: significance for biopharmaceuticals.

Jenkins N, Murphy L, Tyther R.

Mol Biotechnol. 2008 Jun;39(2):113-8. doi: 10.1007/s12033-008-9049-4. Review.

PMID:
18327554
16.

Functional cross-kingdom conservation of mammalian and moss (Physcomitrella patens) transcription, translation and secretion machineries.

Gitzinger M, Parsons J, Reski R, Fussenegger M.

Plant Biotechnol J. 2009 Jan;7(1):73-86. doi: 10.1111/j.1467-7652.2008.00376.x. Epub 2008 Oct 8. Erratum in: Plant Biotechnol J. 2009 Feb;7(2):210.

17.

25 years of recombinant proteins from reactor-grown cells - where do we go from here?

Hacker DL, De Jesus M, Wurm FM.

Biotechnol Adv. 2009 Nov-Dec;27(6):1023-7. doi: 10.1016/j.biotechadv.2009.05.008. Epub 2009 May 20. Review.

PMID:
19463938
18.

Gene amplification and vector engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO cell selection system.

Cacciatore JJ, Chasin LA, Leonard EF.

Biotechnol Adv. 2010 Nov-Dec;28(6):673-81. doi: 10.1016/j.biotechadv.2010.04.003. Epub 2010 Apr 21.

PMID:
20416368
19.

The MADS-domain protein PPM2 preferentially occurs in gametangia and sporophytes of the moss Physcomitrella patens.

Quodt V, Faigl W, Saedler H, Münster T.

Gene. 2007 Oct 1;400(1-2):25-34. Epub 2007 Jun 5.

PMID:
17614216
20.

Bioreactor systems for the production of biopharmaceuticals from animal cells.

Warnock JN, Al-Rubeai M.

Biotechnol Appl Biochem. 2006 Jul;45(Pt 1):1-12. Review.

PMID:
16764553
Items per page

Supplemental Content

Write to the Help Desk